State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome.

@article{Oertel2007StateOT,
  title={State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome.},
  author={Wolfgang Hermann Oertel and Claudia Trenkwalder and Marco Zucconi and Heike Bene{\vs} and Diego Garc{\'i}a Borreguero and C. Bassetti and Markku Partinen and Luigi Ferini-Strambi and Karin Stiasny-Kolster},
  journal={Movement disorders : official journal of the Movement Disorder Society},
  year={2007},
  volume={22 Suppl 18},
  pages={S466-75}
}
Dopaminergic agents are the best-studied agents and are considered first-line treatment of restless legs syndrome (RLS). Extensive data are available for levodopa, pramipexole, and ropinirole, which have approval for the indication RLS, and to a smaller extent for cabergoline, pergolide, and rotigotine. Apart from one recent study, comparing two active drugs (levodopa and cabergoline), no comparative studies have been published. The individual treatment regimen with the most appropriate agent… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 29 extracted citations

Sleep-related movement disorders

Neurological Sciences • 2011
View 7 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…